Papillary adenocarcinoma of the prostatic urethra

Witters S, S Witters, P Moerman, Moerman P, L Vanden Bussche, Vanden Bussche L, R L Vereecken, Vereecken RL
European urology · 1986 · doi:10.1159/000472600 · PMID:2420601
case-report OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-10 ⓘ

This study examined three cases of prostatic urethral papillary adenocarcinoma, finding all three to be prostate-specific antigen positive and detailing their treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Three cases of papillary carcinoma of the prostate (also called endometrial adenocarcinoma of the prostate; endometrioid carcinoma) were studied for prostate-specific antigen in order to determine their origin and histogenesis. All 3 cases were prostate-specific antigen positive. Two patients were treated with hormonal therapy, 1 with radiotherapy.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma, Papillary Prostatic Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma, Papillary Aged Antigens, Neoplasm Antigens, Neoplasm Carcinoma, Papillary Carcinoma, Papillary Endometriosis Endometriosis Humans Immunoenzyme Techniques Male Middle Aged Prostate-Specific Antigen Prostatic Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
unpaywall
last seen: 2026-09-22T06:12:16.469521+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine